Clinical Trial Update: The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methylphenidate plus a chronic fatigue syndrome–specific nutrient formula for Chronic Fatigue Syndrome/Myalgic Encephalomyelit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• CFS-Specific Nutrient Formula
• Methylphenidate (Methylphenidate)

Snippet

Sponsor: K-PAX Pharmaceuticals, Inc. | Conditions: Chronic Fatigue Syndrome (CFS), Myalgic Encephalomyelitis (ME) | Phase 2 | Status: UNKNOWN